# Pomalidomide for Chronic Graft-versus-Host Disease

> **NCT01688466** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 34 (actual)

## Conditions studied

- Graft vs Host Disease
- Graft-Versus-Host Disease

## Interventions

- **DRUG:** Pomalidomide

## Key facts

- **NCT ID:** NCT01688466
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-30
- **Primary completion:** 2017-03-30
- **Final completion:** 2019-05-20
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01688466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01688466, "Pomalidomide for Chronic Graft-versus-Host Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01688466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*